|
|
|
Volumn 9, Issue 50, 2000, Pages 171-174
|
|
Palivizumab in prevention of bronchiolitis
[No Author Info available]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DIURETIC AGENT;
MONOCLONAL ANTIBODY;
OXYGEN;
PALIVIZUMAB;
STEROID;
ADVERSE DRUG REACTION;
ARTICLE;
ARTIFICIAL VENTILATION;
BRONCHIOLITIS;
CHILD;
CLINICAL TRIAL;
CONGENITAL HEART DISEASE;
DOUBLE BLIND PROCEDURE;
DRUG COST;
DRUG EFFICACY;
DRUG MARKETING;
EPIDEMIC;
EVALUATION;
HOSPITALIZATION;
HUMAN;
IMMUNE DEFICIENCY;
INFANT;
INFECTION RISK;
INJECTION;
LUNG DYSPLASIA;
MAJOR CLINICAL STUDY;
MORTALITY;
PREMATURITY;
RESPIRATORY SYNCYTIAL PNEUMOVIRUS;
SEASON;
VIRUS INFECTION;
ANTIBODIES, MONOCLONAL;
BRONCHIOLITIS;
CLINICAL TRIALS;
HUMANS;
INFANT;
INFANT, NEWBORN;
INFANT, PREMATURE;
RESPIRATORY SYNCYTIAL VIRUS INFECTIONS;
TREATMENT OUTCOME;
|
|
EID: 0034458252
PISSN: 11677422
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
|
Times cited : (4)
|
|
References (7)
|
